MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0052697
_PRIVATELIMITED.webp)
Africure Pharmaceuticals (India) Private Limited - pharma in Palghar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹62.65 Cr
▼ 6% YoY
Net profit · FY 2026
₹1.19 Cr
Net margin 1.9%
EBITDA · FY 2026
₹3.32 Cr
EBITDA margin 5.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹20.41 Lakh
Issued & subscribed
Open charges
₹13.5 Cr
Satisfied ₹5 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
104
Provident fund records
About Africure Pharmaceuticals (India) Private Limited
Data last updated:
Africure Pharmaceuticals (India) Private Limited is a private limited company based in Palghar, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24303MH2017PTC291491. Its GSTIN is 27AAPCA2078L1Z6 (Maharashtra). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹20.41 Lakh. It is led by directors including Sanskar Nawal Kumar Tated and Ravi Shankar Chandrasekhar.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 9 – 12 Dewan & Sons Industrial Area Vevoor, Palghar, Maharashtra, India – 401404.
As per the financials filed for FY 2026, the company reported a revenue of ₹62.65 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 1.9%) and EBITDA of ₹3.32 Cr (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 2% over five years.
The company has about 104 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Africure Pharmaceuticals. As per MCA filings, the company has open charges of ₹13.5 Cr and satisfied charges of ₹5 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹6.12 Cr; the latest was in March 2019.
Africure Pharmaceuticals (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0052697). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website africurepharma.com.
Company details
CIN U24303MH2017PTC291491
Registration Number 291491
Incorporation Date 21 February 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0052697
Key People
Sanskar Nawal Kumar Tated Director Ravi Shankar Chandrasekhar Director Susan Teresa Noronha Director Recognitions & Rankings of Africure Pharmaceuticals (India)
Contact details
Africure Pharmaceuticals (India) Private Limited's registered office is in Palghar, Maharashtra. Its website is africurepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address9 – 12 Dewan & Sons Industrial Area Vevoor, Palghar, Maharashtra, India – 401404
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Comprehensive company report
Africure Pharmaceuticals (India) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Africure Pharmaceuticals (India) operates one associated brand: Africure Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Diversified drugs are manufactured and supplied by Africure Pharmaceuticals. | africurepharma.com |
Business activity
The main business activity of Africure Pharmaceuticals (India) is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Africure Pharmaceuticals (India) Private Limited
FY 2026 filings availableAfricure Pharmaceuticals (India) Private Limited reported revenue of ₹62.65 Cr (down 6% YoY) for FY 2026.
Revenue · FY 2026
₹62.65 Cr ▼ 6%
Net profit · FY 2026
₹1.19 Cr margin 1.9%
EBITDA · FY 2026
₹3.32 Cr margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 17%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 30%
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 6% fall in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹62.65 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.32 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.19 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Africure Pharmaceuticals (India) Private Limited
Africure Pharmaceuticals (India) has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanskar Nawal Kumar Tated | Director | 21 Feb 2017 | 9 Years 8 Months | Current |
| Ravi Shankar Chandrasekhar | Director | 21 Feb 2017 | 9 Years 8 Months | Current |
| Susan Teresa Noronha Also directs: Pharma Inputs LLP, Vs3 Golden Years Private Limited | Director | 26 Mar 2021 | 5 Years 7 Months | Current |
Auditor
Africure Pharmaceuticals (India) Private Limited is audited by S G M & Associates LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S G M & Associates LLP | FY 2026 | S200058 |
Shareholding
The shareholding of Africure Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹13.5 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2020 | 100322129 | Hdfc Bank Limited | ₹3.5 Cr | Open | |
| 17 Dec 2019 | 100312605 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 30 Mar 2017 | 100089238 | Others | ₹5 Cr | Satisfied |
To see the full charge records of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Africure Pharmaceuticals (India) Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹6.12 Cr; the latest was in March 2019.
Total deals
1
Funding round
1
Disclosed funding
₹6.12 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Funding round | ₹6.12 Cr | Investors: Africure Pharmaceuticals Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Africure Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Africure Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Africure Pharmaceuticals (India) Private Limited has a workforce of 104 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
104
Active EPFO establishments
1
Employee growth
-2.8%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 104 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Africure Pharmaceuticals (India) Private Limited, buy the company report.
GST
Africure Pharmaceuticals (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPCA2078L1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Africure Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Africure Pharmaceuticals (India) Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Susan Teresa Noronha ceased to be Additional Director on 16 Aug 2021.
Filing
Africure Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Mumbai.
AGM
Africure Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 29 Aug 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 17 Dec 2019 with Charge ID 100312605 was modified on 13 Jun 2024.
Ceased
Susan Teresa Noronha ceased to be Additional Director.
Appointed
Susan Teresa Noronha was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.50 Cr with Charge ID 100322129 was registered on 17 Jan 2020.
Charges
A charge registered on 30 Mar 2017 via Charge ID 100089238 with Others was fully satisfied on 14 Jan 2020.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100312605 was registered on 17 Dec 2019.
Charges
A charge with Others of Rs. 5.00 Cr registered on 30 Mar 2017 with Charge ID 100089238 was modified on 28 Sep 2017.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100089238 was registered on 30 Mar 2017.
Appointed
Ravi Shankar Chandrasekhar was appointed as Director.
Appointed
Sanskar Nawal Kumar Tated was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Africure Pharmaceuticals (India) is an active private limited company based in Palghar, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 February 2017 (9+ years old) and is registered under CIN U24303MH2017PTC291491.
Africure Pharmaceuticals (India) has 3 current directors:
- Sanskar Nawal Kumar Tated - Director
- Ravi Shankar Chandrasekhar - Director
- Susan Teresa Noronha - Director
The latest financial statements of Africure Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 August 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Africure Pharmaceuticals (India) is 27AAPCA2078L1Z6, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Africure Pharmaceuticals (India) is U24303MH2017PTC291491. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Africure Pharmaceuticals (India) was incorporated on 21 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Africure Pharmaceuticals (India) has 1 deal on record (1 funding round), with disclosed funding of ₹6.12 Cr; the latest was in March 2019.
Susan Teresa Noronha ceased to be Additional Director on 16 Aug 2021. Susan Teresa Noronha was appointed as Director on 26 Mar 2021. Ravi Shankar Chandrasekhar was appointed as Director on 21 Feb 2017. Africure Pharmaceuticals (India) has 4 board changes on record in total.
Yes, Africure Pharmaceuticals (India) is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0052697).
Africure Pharmaceuticals (India) can be reached through the website africurepharma.com. Its registered office is in Palghar, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages